KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) EPS (Basic) (2016 - 2025)

Chemed (CHE) has 17 years of EPS (Basic) data on record, last reported at $5.45 in Q4 2025.

  • For Q4 2025, EPS (Basic) fell 10.07% year-over-year to $5.45; the TTM value through Dec 2025 reached $18.42, down 8.31%, while the annual FY2025 figure was $18.42, 8.36% down from the prior year.
  • EPS (Basic) reached $5.45 in Q4 2025 per CHE's latest filing, up from $4.46 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $6.06 in Q4 2024 and bottomed at $3.54 in Q2 2023.
  • Average EPS (Basic) over 5 years is $4.52, with a median of $4.46 recorded in 2022.
  • Peak YoY movement for EPS (Basic): tumbled 31.5% in 2021, then soared 43.17% in 2023.
  • A 5-year view of EPS (Basic) shows it stood at $4.87 in 2021, then decreased by 14.37% to $4.17 in 2022, then surged by 43.17% to $5.97 in 2023, then increased by 1.51% to $6.06 in 2024, then dropped by 10.07% to $5.45 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were $5.45 in Q4 2025, $4.46 in Q3 2025, and $3.6 in Q2 2025.